Chong Kun Dang Publishes First Sustainability Report Disclosing ESG Performance Transparently


  • Chong Kun Dang voluntarily disclosed its 2025 Sustainability Report. This is the company's first integrated ESG report, prepared in accordance with GRI Standards 2021 and verified by Korea Management Registrar.
  • The report covers financial and non-financial performance from January to December 2025, including environmental, social, and governance improvements and future plans.
  • No capital changes or stock-related events occurred during the reporting period; dividend policies or share buybacks are not reported. This disclosure is purely informational with no direct impact on stock price.
  • [AI Summary]The first sustainability report disclosure is a positive signal enhancing Chong Kun Dang's ESG transparency and governance credibility. However, as it contains no direct financial decisions, the short-term stock price impact is limited. In the long run, strengthened sustainability management may favorably influence corporate value.

KOSPI Filing Information


  • Matters Related to Sustainability Management Report, etc. (Voluntary Disclosure)
  • Company: Chong Kun Dang Pharmaceutical (185750)
  • Submission: Chong Kun Dang Pharmaceutical Corp.
  • Under KRX KOSPI Market Division

  • Shares: 13,802,780
  • Price: 64,100 KRW
  • Market Cap: 884.8 B KRW